Jcyteincis A Clinical Stage Biotechnology Company Based In Newport Beachcaliforniafounded In 2012The Company Specializes In Regenerative Cell Therapies Aimed At Treating Retinal Degenerative Disorderswith A Focus On Preserving And Restoring Vision For Patients Suffering From Conditions Like Retinitis Pigmentosarpthe Flagship Productjcellis A Minimally Invasive Therapy That Involves An Intravitreal Injection Of Retinal Progenitor Cellsthese Cells Release Growth Factors To Support Damaged Retinal Cellsjcyte Has Made Significant Progress With Jcelladvancing Through Phase 2 Clinical Trials And Preparing For Phase 3 Trials Following Discussions With The Fdathe Company Has Also Established A Global Licensing Agreement With Santen Pharmaceutical For The Commercialization Of Jcell Outside The U S Which Includes Potential Payments Exceeding $250 Million Jcyte Is Committed To Addressing Unmet Medical Needs In Retinal Diseases And Is Actively Collaborating With Research Partners To Enhance Its Therapeutic Offerings
No conferences found for this company.
| Company Name | Jcyte Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
